List view / Grid view
The FDA has approved the use of Prolia for the treatment…
The FDA has approved the use of Prolia for the treatment of glucocorticoid-induced osteoporosis (GIOP) in men and women at high risk of fracture...
The European Commission has granted marketing authorisation for Mvasi for…
The European Commission has granted marketing authorisation for Mvasi for the treatment of certain types of cancer...
The EMA has accepted the Marketing Authorization Application for romosozumab…
The EMA has accepted the Marketing Authorization Application for romosozumab in the treatment of osteoporosis in postmenopausal women and in men at increased risk of fracture...
